
Professor Frank Chinegwundoh is a Consultant Urological Surgeon. He was appointed as a Consultant to Barts Health NHS Trust and Newham University Hospital NHS Trust in 1996. He is a recognised Teacher of The University of London and in that capacity examines theses for doctoral degrees in urology. At Newham he was Clinical Director for Surgery and Anaesthesia until October 2012. In 2008 he received a national Clinical Excellence Award and in 2013 was awarded an MBE for services to the NHS. He is a recognised expert in the field of prostate cancer and is invited to speak at international meetings. Professor Chinegwundoh published the first paper in the UK to show that black men in the UK have a three-fold excess risk of developing prostate cancer compared to white men. He has numerous publications and book chapters. He is an honorary Senior Clinical Lecturer, University of London. Professor Chinegwundoh is the co-chair of the Prostate Cancer Advisory Group set up by the Department of Health. He is a member of the Bowel Screening Advisory Committee. He is a member of the scientific reference committee of the Prostate Cancer Risk Management Programme. In late 2014 he was the clinical lead for the ‘Be clear on cancer: prostate cancer’ initiative. He is a trustee of the charity National Federation of Prostate Cancer Support Groups aka Tackle Prostate Cancer. Since 1998 he has been Chairman of the charity Cancer Black Care, based in London. He provides a tertiary service in the North East London Cancer Network for prostate brachytherapy and prostate cryotherapy. Indeed, the only urologist able to deliver those services. Professor Chinegwundoh also provides a transperineal template biopsy service, which is the gold standard for diagnosing prostate cancer. Apart from expertise in prostate cancer therapies he is also able to employ a variety of technologies to deal with the enlarged benign prostate, for example TURP, TURIS, TUNA. In 2010 he graduated with a Master of Medical Law degree from Glasgow University. In 2002 he was appointed visiting Professor in Urology to University of Nigeria Teaching Hospital in Enugu, Nigeria. Professor Chinegwundoh’s wife is a local GP in Chingford. He has two teenage children. In December 2014 he was appointed Honorary Visiting Professor in the School of Health Sciences, City University London.
Selected publications from PubMed
Prostate cancer screening: better outcomes from early detection.
Chinegwundoh FI
BMJ. 2023 Aug 18;382:1842 doi: 10.1136/bmj.p1842.
Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.
Moore CM, King LE, Withington J, Amin MB, Andrews M, Briers E, Chen RC, Chinegwundoh FI, Cooperberg MR, Crowe J, Finelli A, Fitch MI, Frydenberg M, Giganti F, Haider MA, Freeman J, Gallo J, Gibbs S, Henry A, James N, Kinsella N, Lam TBL, Lichty M, Loeb S, Mahal BA, Mastris K, Mitra AV, Merriel SWD, van der Kwast T, Van Hemelrijck M, Palmer NR, Paterson CC, Roobol MJ, Segal P, Schraidt JA, Short CE, Siddiqui MM, Tempany CMC, Villers A, Wolinsky H, MacLennan S
Eur Urol Oncol. 2023 Apr;6(2):160-182 doi: 10.1016/j.euo.2023.01.003.
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.
Grey ADR, Scott R, Shah B, Acher P, Liyanage S, Pavlou M, Omar R, Chinegwundoh F, Patki P, Shah TT, Hamid S, Ghei M, Gilbert K, Campbell D, Brew-Graves C, Arumainayagam N, Chapman A, McLeavy L, Karatziou A, Alsaadi Z, Collins T, Freeman A, Eldred-Evans D, Bertoncelli-Tanaka M, Tam H, Ramachandran N, Madaan S, Winkler M, Arya M, Emberton M, Ahmed HU
Lancet Oncol. 2022 Mar;23(3):428-438 doi: 10.1016/S1470-2045(22)00016-X.
The relationship between Black men with prostate cancer and their health-care providers.
Chinegwundoh FI
Nat Rev Urol. 2021 Dec;18(12):701-702 doi: 10.1038/s41585-021-00525-6.
Large bowel obstruction from advanced prostate cancer in a 41-year-old: the role of genetic testing.
Jonosky JB, De Villiers N, Wadee R, Chinegwundoh F, Adam A
S Afr J Surg. 2020 Sep;58(3):163.

Ethnic diversity provides a diversity of thought. In the UK, the acronym BAME stands for people from Black, Asian and Ethnic Minority backgrounds. Many scientific publications have shown that BAME do worse in Part A and B of the MRCS exams and their academic performance is worse. When it comes to leadership in surgery, BAME is underrepresented in leadership of surgery in the UK. The websites of the Royal Surgical Colleges and 24 other surgical specialty associations show that there are around 550 leaders but only 20% of them are BAME.. Dr. Chinegwundoh argues that we must recognize that ethnic minorities are systematically excluded from surgical leadership. Racism is present in the world of medicine and surgery is not immune. Dr. Chinegwundoh discusses his undergraduate and graduate experience and his career progression. He also describes the experience of belonging to an ethnic minority and what being the leader of a surgical service is like, referring also to other colleagues such as Martin Griffith, the National Clinical Director for Violence Reduction.
Published
Oct 2021

Challenges and Solutions to Diversity Part 1, divided into: Challenges to women surgeons in Asia – Dr April Roslani (Malaysia), Black surgeons as leaders – Dr. Francis Chinegwundoh (UK), The importance of mentoring – Dr L.D. Britt (USA), Women surgeons as mentors – Dr Tracy Hull (USA), Women surgeons as leaders – Dr Valerie Rusch (USA), Diversity in innovation at J&J – Dr Charles Bridges (USA), Discussion – All faculty moderated by Dr Steven Wexner (USA), Dr Patricia Turner (USA) and Dr Mariana Berho (USA)
With Johnson & Johnson MedTech
Published
Mar 2021
Help your network discover Dr. Francis Chinegwundoh's clinical expertise.